M&T Bank’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-4,673
Closed -$270K – 1626
2022
Q1
$270K Buy
4,673
+343
+8% +$18.8K ﹤0.01% 1250
2021
Q4
$255K Buy
4,330
+49
+1% +$2.97K ﹤0.01% 1328
2021
Q3
$261K Sell
4,281
-17
-0.4% -$997 ﹤0.01% 1303
2021
Q2
$258K Buy
+4,298
New +$215K ﹤0.01% 1329

Other funds holding ATEX

M&T Bank's ATEX Position: Q2 2022 in Review

M&T Bank sold out of Anterix (ATEX) in Q2 2022, closing a stake of 4,673 shares — an estimated $270K sold.

M&T Bank first reported a position in ATEX in Q2 2021 and held it in 4 quarters. The position peaked at $270K in Q1 2022. 94 funds tracked by Wall St. Rank hold ATEX as of Q2 2022.

  • M&T Bank reported no remaining Anterix position as of Q2 2022 after selling out during the quarter.
  • M&T Bank sold 4,673 Anterix shares in Q2 2022, an estimated $270K.
  • M&T Bank first reported a position in Anterix in Q2 2021 and held it in 4 quarters.
  • M&T Bank's Anterix position peaked at $270K in Q1 2022.
  • 94 funds tracked by Wall St. Rank held Anterix as of Q2 2022.

Based on M&T Bank's 13F filing for Q2 2022, filed 5 Aug 2022.